About Sonostar Ventures
Sonostar Ventures is a venture capital firm founded in 1997. It is primarily based out of Chappaqua, United States. As of Mar 2022, Sonostar Ventures has invested in 27 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Consumer and Retail. Most recently it participated in the $***** Seed round of Plum Life Overall, Sonostar Ventures portfolio has seen 6 IPOs and 10 acquisitions including key companies like Grab, Kite Pharma and Kronos Bio. A lot of funds co-invest with Sonostar Ventures, with names like Jesse Horwitz sharing a substantial percentage of its portfolio. Sonostar Ventures has team of 3 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series B & 1 more
Portfolio IPOs
Portfolio Acquisitions
Sonostar Ventures' List of Top Investments
Sonostar Ventures has a portfolio of 27 companies. Their most notable investments are in Plum Life and UroGen Pharma.Their portfolio spans across United States, Israel and Singapore. They have invested in Life Sciences, Consumer, Retail and 14 other sectors, across stages such as Seed, Series B and 1 more. Here is the list of top investments by Sonostar Ventures:1. Grab
Operator of a platform providing ride, food, mart, and express services. The platform offers options for transportation, food delivery, grocery and goods, and package delivery. It also provides financial services, gift options, and rewards programs for users. Additionally, the platform extends tools and resources for drivers and merchants to facilitate their operations.
Key facts about Grab
- Founded Year: 2012
- Location: Singapore (Singapore)
- Annual Revenue: 2.8B SGD as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $10.4B
- Employee Count: 11,934 as on Dec 31, 2023
- Investors: Glean Management, Angelneers and 104 Others
- Latest Funding Round: Post IPO, Jul 27, 2021, $*****
- Highlight: Public
2. Kite Pharma
Developer of cancer immunotherapy products using genetic engineering. The company's product Yescarta a CAR-T therapy for the treatment of adult patients with relapsed or refractory large B-Cell lymphoma and TECARTUS is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.
Key facts about Kite Pharma
- Founded Year: 2009
- Location: Los Angeles (United States)
- Annual Revenue: $28.8B as on Dec 31, 2024
- Stage: Acquired
- Total Funding till date: $97.7M
- Employee Count: 17 as on Dec 31, 2022
- Investors: BB Biotech, Amgen Business Development and 10 Others
- Latest Funding Round: Post IPO, Apr 03, 2018, $*****
- Highlight: Acquired
_1548135965397.png?format=webp&height=120&width=120){kind=logo}
3. Kronos Bio
Developer of small molecule-based therapeutics for cancer treatment. The company has developed small molecules that bind or interfere with the target protein activity directly, disrupt protein-protein complexes, or affect nearest neighbor proteins that may indirectly modulate target activity.
Key facts about Kronos Bio
- Founded Year: 2017
- Location: San Mateo (United States)
- Annual Revenue: $9.85M as on Dec 31, 2024
- Stage: Acquired
- Total Funding till date: $271M
- Employee Count: 97 as on Dec 31, 2022
- Investors: Commodore Capital, Citadel and 18 Others
- Latest Funding Round: Series B, Aug 24, 2020, $*****
- Highlight: Acquired
4. Andie
Provider of swimsuits. It is an internet-first brand offering one-piece women's swimsuits. The product catalog includes one-pieces, two-pieces, maternity, and more.
Key facts about Andie
- Founded Year: 2016
- Location: New York City (United States)
- Stage: Series B
- Total Funding till date: $27.5M
- Employee Count: 34 as on Jul 01, 2024
- Investors: Sonostar Ventures, Marcy Venture Partners and 8 Others
- Latest Funding Round: Series B, Dec 14, 2021, $*****
- Highlight: Editors' Pick
Developer of therapeutics to treat urothelial and specialty cancers. The company uses proprietary technology RTGel to deliver targeted therapies which include "Jelmyto" for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer.
Key facts about UroGen Pharma
- Founded Year: 2004
- Location: Ra anana (Israel)
- Stage: Public
- Total Funding till date: $7M
- Employee Count: 174 as on Jul 01, 2024
- Investors: RA Capital Management, RTW Investments and 10 Others
- Latest Funding Round: Post IPO, Jul 27, 2023, $*****
- Highlight: Public
Sonostar Ventures' Year-on-Year Investment Trends
Sonostar Ventures has invested in 27 companies over the last 16 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Plum Life and most recent follow-on round was in Plum Life.Sonostar Ventures' Investments by Stage
Sonostar Ventures has made 2 investments in Seed stage with an average round size of $2.24M, 1 investment in Series B stage and 1 investment in Series C stage with an average round size of $6.5M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Sonostar Ventures' Investments by Sector
Sonostar Ventures has a diverse portfolio, with companies operating in the Life Sciences, Consumer, Consumer Goods, Enterprise Applications and FinTech. Notably, it has invested in 17 Enterprise (B2B) companies, 15 Tech companies, 8 Consumer (B2C) companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Consumer | 1 |
Consumer Goods | 1 |
Enterprise Applications | 1 |
FinTech | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Sonostar Ventures' Investments by Geography
Sonostar Ventures has made most investments in United States (3), followed by Israel where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 3 |
Israel | 1 |
Note: We have considered here, only first round of investments
Sonostar Ventures' recent investments
Sonostar Ventures has not made any investment in 2026 so far.Here are the most recent investments by Sonostar Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 02, 2022 | United States | Seed | 7095 | ||
Oct 21, 2021 | United States | Seed | 5396 | - | |
Oct 08, 2020 | United States | Series A | 3116 | ||
Mar 21, 2018 | United States | Seed | 6615 | ||
2016 | Israel | Series B | 8209 | - |
IPOs and Publicly Listed companies in Sonostar Ventures' Portfolio
6 of Sonostar Ventures' portfolio companies have become public. Grab got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Dec 2021 at marketcap of $40B and Allogene Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Sonostar Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 01, 2021 | - | - | 7710 | |
Oct 11, 2018 | - | - | 8257 | |
May 04, 2017 | 2016 | Series B | 6577 | |
Nov 17, 2014 | - | - | 7171 | |
Jun 05, 2000 | - | - | 4624 |
Acquired companies in Sonostar Ventures' Portfolio
10 companies from Sonostar Ventures' portfolio have been acquired. The most recent acquisition were Kronos Bio in May 2025 by Concentra Biosciences.Here are Sonostar Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 01, 2025 | - | - | 2064 | |
Jun 04, 2024 | Oct 21, 2021 | Seed | 8146 | |
Nov 29, 2022 | - | - | 3430 | |
Aug 08, 2022 | - | - | 1623 | |
Nov 29, 2021 | - | - | 9807 |
_1548135965397.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of Sonostar Ventures
Sonostar Ventures has a team of 3 members including 3 Partners located in United States. Sonostar Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Sonostar Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Chappaqua | - | - | |
Partner | New York City | - | - | |
Partner | New York City | - | - |
Co-investors of Sonostar Ventures
Over the past 16 years, 18 investors have co-invested in Sonostar Ventures's portfolio companies. This includes funds and angels.
- Invested before Sonostar Ventures: Pontifax, Riverbank Capital Securities and 2 others have invested in rounds before Sonostar Ventures. There is 1 company where Pontifax has invested before Sonostar Ventures and 1 company where Riverbank Capital Securities has invested before Sonostar Ventures.
- Top Co-investors of Sonostar Ventures: 2 investors entered a company along with Sonostar Ventures. These include investors like Jesse Horwitz (1 company).
- Invested after Sonostar Ventures: A total of 12 investors have invested in Sonostar Ventures's portfolio after their investments. Top Investors include CityRock Venture Partners (1 company), Trail Mix Ventures (1 company) and Marcy Venture Partners (1 company).
Recent News related to Sonostar Ventures
•
Plum Life Raises $5.3M in Seed FundingFinSMEs•Mar 03, 2022•Plum Life, ManchesterStory Group, MTech Capital, Sonostar Ventures
•
Plum Life Raises $2.45M for Advisor-Focused PlatformInsurance Innovation Reporter•Oct 23, 2021•Plum Life, Sonostar Ventures
•
Andie Swim Raises $6.5 Million Series A Round to Transform the Data Driven Swimwear Ecommerce ExperiencePR Newswire•Oct 08, 2020•Andie, CityRock Venture Partners, Trail Mix Ventures, Sonostar Ventures
